Assessment of private health sector prescribing patterns and adherence to prescription format using World Health Organization core drug use indicators in Addis Ababa, Ethiopia

被引:3
|
作者
Asmamaw, Getahun [1 ]
Ejigu, Nahu [2 ]
Tewihubo, Dinksew [3 ]
Ayenew, Wondim [4 ]
机构
[1] Arba Minch Univ, Dept Pharm, Arba Minch, Ethiopia
[2] Arabisa Hlth Ctr, Addis Ababa, Ethiopia
[3] Medda Wolabu Univ, Dept Pharm, Bale Robe, Ethiopia
[4] Univ Gondar, Dept Pharmaceut, Gondar, Ethiopia
关键词
Ethiopia; Prescribing patterns; WHO core drug use indicators; Private healthcare sector; CARE; FACILITIES; PROVIDERS; CLINICS;
D O I
10.1186/s40545-022-00408-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Currently, the private healthcare sector's role in healthcare delivery is growing in Ethiopia. However, there are limited studies on private healthcare sector drug use patterns. This study aimed to evaluate the private healthcare sector prescribing practices and adherence to prescription format, using some of the World Health Organization (WHO) core drug use indicators in Addis Ababa, Ethiopia. Methods A retrospective cross-sectional study design was used to collect quantitative data from prescriptions prescribed and dispensed by private healthcare sectors in the Lemi-Kura sub-city, Addis Ababa. The study was conducted from June to July 2021. The WHO criteria were used to evaluate prescribing and prescription completeness indicators. Prescriptions, kept for the last 1 year that were prescribed between January 1, 2020, to January 1, 2021, by private drug outlets, were analyzed. Simple random and systematic sampling procedures were employed in selecting drug outlets and prescriptions, respectively. Results Of a total of 1,200 prescriptions, 2,192 drugs were prescribed and the average number of drugs per prescription was 1.83. Generic names, antibiotics, injections, and drugs on the Ethiopian essential medicines list accounted for 77.4, 63.8, 11.5, and 80.6% of all prescriptions, respectively. Among the patient identifiers, the patient card number (54.3%), weight (2.3%), and diagnoses (31.7%) were less likely to be completed. In terms of the drug-related information, the dosage form (35.5%) was the least likely to be completed. Only 36.6 and 25.8% of prescriptions contained the names and qualifications of the prescribers, respectively. It was difficult to obtain prescription papers with the dispenser identifier. Conclusion The study findings indicated prescribing and prescription completeness indicators all considerably deviated from WHO standards and hence unsuitable. This situation could be critical since a similar pattern is reported from public healthcare sectors, which might imply the extent of non-adherence to WHO core drug use standards. Consequently, it could play a considerable role in increasing irrational medicine use in Ethiopia.
引用
收藏
页数:10
相关论文
共 39 条
  • [32] ASSESSMENT OF CORE DRUG USE INDICATORS USING WHO/INRUD METHODOLOGY AT PRIMARY HEALTH CARE CENTERS IN BAHAWALPUR, PAKISTAN
    Atif, M.
    Qamar-Uz-Zaman, M.
    Sarwar, Rehan M.
    Azeem, M.
    VALUE IN HEALTH, 2016, 19 (07) : A445 - A445
  • [33] Evaluation of Rational Use of Medicine Using WHO/INRUD Core Drug Use Indicators at Teda and Azezo Health Centers, Gondar Town, Northwest Ethiopia
    Sema, Faisel Dula
    Asres, Esubalew Delie
    Wubeshet, Belaynesh Dubale
    INTEGRATED PHARMACY RESEARCH AND PRACTICE, 2021, 10 : 51 - 63
  • [34] Assessment of World Health Organisation core drug use indicators in tertiary care hospital of Kathmandu, Nepal: A cross-sectional study
    Ghimire, Rakesh
    Bhandari, Bijay
    Poudel, Nirmal
    Pradhan, Sandesh
    Kharel, Shristi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 209 - 209
  • [35] INVESTIGATING RATIONAL USE OF PRESCRIPTION DRUGS IN SAUDI MINISTRY OF HEALTH HOSPITALS USING WORLD HEALTH ORGANIZATION LEVEL-II INDICATORS; DOES THE PHARMACY AND THERAPEUTICS COMMITTEE HAVE AN IMPACT?
    Alkelya, M. A.
    Amin, R. M.
    AlJeraisy, M.
    Zamakhshary, M.
    VALUE IN HEALTH, 2013, 16 (03) : A97 - A97
  • [36] National survey on World Health Organization/International Network of Rational Use of Drugs core drug use indicators in the outpatient setting and availability of medicines in a developing South Asian country
    Ranasinghe, P.
    Liyanage, C. K.
    Meegoda, J.
    Jayakody, R. L.
    Galappatthy, P.
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2022, 13 (02) : 158 - 165
  • [37] Assessment of nonsteroidal anti-inflammatory drug use pattern using World Health Organization indicators: A cross-sectional study in a tertiary care teaching hospital of Chhattisgarh
    Vaishnavi, P. R. R.
    Gaikwad, Nitin
    Dhaneria, S. P.
    INDIAN JOURNAL OF PHARMACOLOGY, 2017, 49 (06) : 445 - 450
  • [38] Evaluation of prescription completeness, rational drug-use patterns using WHO prescribing, patient-care and facility indicators in Debre Tabor Comprehensive Specialized Hospital, Ethiopia: A cross-sectional study
    Yimer, Yohannes Shumet
    Addis, Getu Tesfaw
    Alemu, Muluken Adela
    SAGE OPEN MEDICINE, 2022, 10
  • [39] Assessment of prescribing pattern of drugs and completeness of prescriptions as per the World Health Organization prescribing indicators in various Indian tertiary care centers: A multicentric study by Rational Use of Medicines Centers-Indian Council of Medical Research network under National Virtual Centre Clinical Pharmacology activity
    Joshi, R.
    Medhi, B.
    Prakash, A.
    Chandy, S.
    Ranjalkar, J.
    Bright, H.
    Basker, J.
    Govindraj, L.
    Chugh, P.
    Tripathi, C.
    Badyal, D.
    Balakrishnan, S.
    Jhaj, R.
    Shukla, A.
    Atal, S.
    Najmi, A.
    Banerjee, A.
    Kamat, S.
    Tripathi, R.
    Shetty, Y.
    Parmar, U.
    Rege, N.
    Dikshit, H.
    Mishra, H.
    Roy, S.
    Chatterjee, S.
    Hazra, A.
    Bhattacharya, M.
    Das, D.
    Trivedi, N.
    Shah, P.
    Chauhan, J.
    Desai, C.
    Gandhi, A.
    Patel, P.
    Shah, S.
    Sheth, S.
    Raveendran, R.
    Mathaiyan, J.
    Manikandan, S.
    Jeevitha, G.
    Gupta, P.
    Sarangi, S.
    Yadav, H.
    Singh, S.
    Kaushal, S.
    Arora, S.
    Gupta, K.
    Jain, S.
    Cherian, J.
    INDIAN JOURNAL OF PHARMACOLOGY, 2022, 54 (05) : 321 - 328